Announcement on Implementation of Quarterly Dividend Distribution for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Quarterly Dividend Distribution for 2025
Filed with SSE · · 3 pages · Chinese
Release
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix
Earlier from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Appointment of Senior Management Member
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Branch Obtaining Drug Registration Certificate
- Announcement on Convening the Q3 2025 Performance Briefing
Later from Tianjin Pharmaceutical Da Ren Tang
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Change of Sponsor Representative for Continuous Supervision
- Special Report on Deposit and Actual Use of Raised Funds
- Announcement on Adding Provisional Proposal at the 2025 Annual General Meeting
- Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025 and "Corporate Value and Return Enhancement" Action Plan 2026
Follow Tianjin Pharmaceutical Da Ren Tang into a list and get an email when it puts out news.
Follow Tianjin Pharmaceutical Da Ren Tang